Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database
2010

Trends in CD4 Counts in HIV Patients on Antiretroviral Treatment

Sample size: 1676 publication Evidence: moderate

Author Information

Author(s): Zhou Jialun, Sirisanthana Thira, Kiertiburanakul Sasisopin, Chen Yi-Ming, Han Ning, Lim Poh_Lian, Kumarasamy Nagalingeswaran, Choi Jun Yong, Merati Tuti Parwati, Yunihastuti Evy, Oka Shinichi, Kamarulzaman Adeeba, Phanuphak Praphan, Lee Christopher KC, Li Patrick CK, Pujari Sanjay, Saphonn Vanthanak, Law Matthew G

Primary Institution: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia

Hypothesis

The study aims to examine the relationship between trends in CD4 counts and HIV viral load after initiation of combination antiretroviral treatment in Asian patients.

Conclusion

CD4 counts continued to increase after starting treatment, even with detectable HIV viral load, but needed to be controlled at lower levels to maintain a positive CD4 count slope over time.

Supporting Evidence

  • The median time on combination antiretroviral treatment was 4.2 years.
  • CD4 count slope was associated with age, concurrent HIV viral load, and disease stage.
  • CD4 counts continued to increase with HIV viral load up to 20,000 copies/mL during the first 6-12 months after treatment initiation.

Takeaway

This study shows that HIV patients can still improve their immune health even if the virus is detectable, but they need to keep the virus levels low to keep getting better.

Methodology

The study included treatment-naive HIV-infected patients who started combination antiretroviral treatment and had multiple CD4 count and HIV viral load tests, analyzing data using random-effects linear regression models.

Potential Biases

The study may be biased due to the urban referral center setting and the selection of patients considered to have a good prospect for long-term follow-up.

Limitations

The study's patient population may not represent all HIV-infected individuals in the Asia-Pacific region, and there is a lack of data on treatment adherence and survival outcomes.

Participant Demographics

The median age of participants was 36 years, with 74% male and 12% having hepatitis B or C co-infection.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2334-10-361

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication